HealthcareFDA accepts SpringWorks' application for mirdametinib for NF1-PNBy Helitra.com·August 29, 2024·1 min read FDA accepts SpringWorks’ application for mirdametinib for NF1-PN Source: SeekingalphaADVERTISEMENT ADVERTISEMENTaccepts application FDA mirdametinib NF1PN SpringWorks039 Post navigation Previous storyPfizer in collaboration with Quotient Therapeutics for CV, kidney disease therapiesNext storyKrystal Biotech's Jeune reports promising phase 1 data on wrinkles drug
Fitness · HealthcareWhat to Wear for Menopause Hot FlashesNovember 4, 2026Whether you’re presenting in a boardroom, on a packed rush hour train, or trying to get back to sleep at 3 a.m., hot…
Fitness · HealthcareShemar Moore Opens Up About His 3-Surgery Journey To Fix His BunionsNovember 4, 2026Even at the peak of his modeling career, Shemar Moore was wrestling with a vulnerability he kept strictly out of frame. The 56-year-old…
Fitness · Healthcare4 Dermatologists Explain Why Bar Soap Isn’t Bad for Your SkinNovember 4, 2026In the age of TikTok, multi-step skincare routines are more ubiquitous than ever. And if you’re anything like me, you’ve watched more facial…